Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Non-invasive Prenatal Testing (NIPT) Market, by Product
1.4.2 Europe Non-invasive Prenatal Testing (NIPT) Market, by Application
1.4.3 Europe Non-invasive Prenatal Testing (NIPT) Market, by End User
1.4.4 Europe Non-invasive Prenatal Testing (NIPT) Market, by Technology
1.4.5 Europe Non-invasive Prenatal Testing (NIPT) Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Europe Non-invasive Prenatal Testing (NIPT) Market by Product
4.1 Europe Consumables & Reagents Market by Country
4.2 Europe Instruments Market by Country
Chapter 5. Europe Non-invasive Prenatal Testing (NIPT) Market by Application
5.1 Europe Trisomy Market by Country
5.2 Europe Microdeletion Syndrome Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Non-invasive Prenatal Testing (NIPT) Market by End User
6.1 Europe Diagnostic Laboratories Market by Country
6.2 Europe Hospitals & Clinics Market by Country
Chapter 7. Europe Non-invasive Prenatal Testing (NIPT) Market by Technology
7.1 Europe Next Generation Sequencing (NGS) Market by Country
7.2 Europe Microarray Market by Country
7.3 Europe Polymerase Chain Reaction (PCR) Market by Country
7.4 Europe Rolling Circular Amplification Market by Country
Chapter 8. Europe Non-invasive Prenatal Testing (NIPT) Market by Country
8.1 Germany Non-invasive Prenatal Testing (NIPT) Market
8.1.1 Germany Non-invasive Prenatal Testing (NIPT) Market by Product
8.1.2 Germany Non-invasive Prenatal Testing (NIPT) Market by Application
8.1.3 Germany Non-invasive Prenatal Testing (NIPT) Market by End User
8.1.4 Germany Non-invasive Prenatal Testing (NIPT) Market by Technology
8.2 UK Non-invasive Prenatal Testing (NIPT) Market
8.2.1 UK Non-invasive Prenatal Testing (NIPT) Market by Product
8.2.2 UK Non-invasive Prenatal Testing (NIPT) Market by Application
8.2.3 UK Non-invasive Prenatal Testing (NIPT) Market by End User
8.2.4 UK Non-invasive Prenatal Testing (NIPT) Market by Technology
8.3 France Non-invasive Prenatal Testing (NIPT) Market
8.3.1 France Non-invasive Prenatal Testing (NIPT) Market by Product
8.3.2 France Non-invasive Prenatal Testing (NIPT) Market by Application
8.3.3 France Non-invasive Prenatal Testing (NIPT) Market by End User
8.3.4 France Non-invasive Prenatal Testing (NIPT) Market by Technology
8.4 Russia Non-invasive Prenatal Testing (NIPT) Market
8.4.1 Russia Non-invasive Prenatal Testing (NIPT) Market by Product
8.4.2 Russia Non-invasive Prenatal Testing (NIPT) Market by Application
8.4.3 Russia Non-invasive Prenatal Testing (NIPT) Market by End User
8.4.4 Russia Non-invasive Prenatal Testing (NIPT) Market by Technology
8.5 Spain Non-invasive Prenatal Testing (NIPT) Market
8.5.1 Spain Non-invasive Prenatal Testing (NIPT) Market by Product
8.5.2 Spain Non-invasive Prenatal Testing (NIPT) Market by Application
8.5.3 Spain Non-invasive Prenatal Testing (NIPT) Market by End User
8.5.4 Spain Non-invasive Prenatal Testing (NIPT) Market by Technology
8.6 Italy Non-invasive Prenatal Testing (NIPT) Market
8.6.1 Italy Non-invasive Prenatal Testing (NIPT) Market by Product
8.6.2 Italy Non-invasive Prenatal Testing (NIPT) Market by Application
8.6.3 Italy Non-invasive Prenatal Testing (NIPT) Market by End User
8.6.4 Italy Non-invasive Prenatal Testing (NIPT) Market by Technology
8.7 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market
8.7.1 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by Product
8.7.2 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by Application
8.7.3 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by End User
8.7.4 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by Technology
Chapter 9. Company Profiles
9.1 Illumina, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Natera Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 SWOT Analysis
9.3 F. Hoffmann-La Roche Ltd.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 PerkinElmer, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Acquisition and Mergers:
9.4.6 SWOT Analysis
9.5 Laboratory Corporation of America Holdings
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental Analysis
9.5.4 SWOT Analysis
9.6 Eurofins Scientific SE
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Recent strategies and developments:
9.6.4.1 Product Launches and Product Expansions:
9.6.5 SWOT Analysis
9.7 Thermo Fisher Scientific, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 WOT Analysis
9.8 GE HealthCare Technologies, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Product Launches and Product Expansions:
9.8.5.2 Acquisition and Mergers:
9.8.6 SWOT Analysis
9.9 Agilent Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 SWOT Analysis
9.10. Pacific Biosciences of California, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Acquisition and Mergers:
9.10.6 SWOT Analysis